Differences in management of older women influence breast cancer survival: Results from a population-based database in Sweden

PLoS Medicine

Volumn 3, Issue 3, 2006, Pages 321-328

  Eaker, Sonja ^a   Dickman, Paul W ^b   Bergkvist, Leif ^c   Holmberg, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; SWEDEN; AGE DISTRIBUTION; BREAST TUMOR; CONFIDENCE INTERVAL; FACTUAL DATABASE; MIDDLE AGED; PATHOLOGY; SURVIVAL;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; SWEDEN;

EID: 33645362243     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030025     Document Type: Article

References (15)

1. Swedish Cancer Registry (2004) Cancer incidence in Sweden 2003. Stockholm (Sweden): National Board of Health and Welfare. 36 p.
2. Kimmick G, Muss HB (2004) Breast cancer in older patients. Semin Oncol 31: 234-248.
3. Wyld L, Reed MW (2003) The need for targeted research into breast cancer in the elderly. Br J Surg 90: 388-399.
4. Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L (1999) Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85: 1104-1113.
5. Woodard S, Nadella PC, Kotur L, Wilson J, Burak WE, et al. (2003) Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: Evidence of possible age bias? Cancer 98: 1141-1149.
6. Regional Oncologic Centre in Uppsala/Örebro Region (2004) Vårprogram för cancer mammae. Uppsala (Sweden): Regional Oncologic Centre in Uppsala/Örebro Region. Available: http://www.roc.se/. Accessed 16 November 2005.
7. Ederer F, Axtell LM, Cutler SJ (1961) The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 6: 101-121.
8. Dickman PW, Sloggett A, Hills M, Hakulinen T (2004) Regression models for relative survival. Stat Med 23: 51-64.
9. Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS (2003) Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med 138: 90-97.
10. Diab SG, Elledge RM, Clark GM (2000) Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92: 550-556.
11. Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML (2005) Breast cancer treatment guidelines in older women. J Clin Oncol 23: 783-791.
12. Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, et al. (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351: 963-970.
13. Deutsch M (2002) Radiotherapy after lumpectomy for breast cancer in very old women. Am J Clin Oncol 25: 48-49.
14. Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, et al. (2005) Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293: 1073-1081.
15. Crivellari D, Bonetti M, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, et al. (2000) Burdens and bene.ts of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII. J Clin Oncol 18: 1412-1422.